{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:04:42Z","timestamp":1757574282038},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/bf00165153","type":"journal-article","created":{"date-parts":[[2004,11,5]],"date-time":"2004-11-05T20:14:00Z","timestamp":1099685640000},"page":"13-17","source":"Crossref","is-referenced-by-count":18,"title":["A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors"],"prefix":"10.1007","volume":"2","author":[{"given":"Lynn G.","family":"Feun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Kwan A.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milam E.","family":"Leavens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Andrews","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenie A.","family":"Obbens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agop Y.","family":"Bedikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niramol","family":"Savaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. P.","family":"Bodey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"213","volume":"19","author":"AH Khan","year":"1976","unstructured":"Khan AH and Driscoll JS: Potential central nervous system antitumor agents ? aziridinylbenzoquinone. J Med Chem 19:213?317, 1976.","journal-title":"J Med Chem"},{"key":"CR2","first-page":"527","volume":"61","author":"LB Mellet","year":"1977","unstructured":"Mellet LB: Physicochemical consideration and pharmacokinetic behavior in delivery of drugs to the central nervous system. Cancer Treat Rep 61:527?531, 1977.","journal-title":"Cancer Treat Rep"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jps.2600680217","volume":"68","author":"JS Driscol","year":"1979","unstructured":"Driscol JS, Dudeck L, Congleton G, Geran RI: Potential CNS antitumor agents VI. J Pharm Sci 68:185?188, 1979.","journal-title":"J Pharm Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/jm00233a010","volume":"19","author":"FL Chou","year":"1976","unstructured":"Chou FL, Khan AH, Dricsol JS: Potential central nervous system antitumor agents ? aziridinylbenzoquinone. J Med Chem 19:1302?1308, 1976.","journal-title":"J Med Chem"},{"key":"CR5","first-page":"194","volume":"87","author":"JS Driscoll","year":"1977","unstructured":"Driscoll JS: Aziridinylquinone antitumor agents. Chem Abste 87:194?230, 1977.","journal-title":"Chem Abste"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00153636","volume":"1","author":"NS Savaraj","year":"1983","unstructured":"Savaraj NS, Lu K, Fenn LF, Leavens ME, Stewart D, Benjamin RS, Loo TL: Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis (carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986) J Neuro-Oncol 1: 15?19, 1983.","journal-title":"J Neuro-Oncol"},{"key":"CR7","first-page":"459","volume":"4","author":"AY Bedikian","year":"1981","unstructured":"Bedikian AY, Bodey GP, Burgess MA, Freireich EJ: Phase I study of aziridinylbenzoquinone (NSC 182986). Cancer Clin Trials 4:459?463, 1981.","journal-title":"Cancer Clin Trials"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457?481, 1958.","journal-title":"J Am Stat Assoc"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/biomet\/52.1-2.203","volume":"52","author":"EA Gehan","year":"1965","unstructured":"Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203?223, 1965.","journal-title":"Biometrika"},{"key":"CR10","first-page":"2071","volume":"62","author":"VA Levin","year":"1978","unstructured":"Levin VA, Hoffman WK, Pischer TL et al: BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors. Cancer Treat Rep 62:2071?2076, 1978.","journal-title":"Cancer Treat Rep"},{"key":"CR11","first-page":"45","volume":"1","author":"LG Feun","year":"1983","unstructured":"Feun LG, Stewart DJ, Leavens ME et al: A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignan brain tumors. J Neuro-Oncol 1:45?48, 1983.","journal-title":"J Neuro-Oncol"},{"key":"CR12","first-page":"24","volume":"1","author":"RS Aroney","year":"1982","unstructured":"Aroney RS, Kaplan RS, Saleman M et al: A phase II trial of AZQ (NSC 182986) in patients with recurrent primary or metastatic brain tumors. ASCO (Abstract) 1:24, 1982.","journal-title":"ASCO (Abstract)"},{"key":"CR13","first-page":"13","volume":"1","author":"GA Curt","year":"1982","unstructured":"Curt GA, Schilsky R, Kelly J et al: Phase II study of AZQ in malignant high-grade gliomas. ASCO (Abstract) 1:13, 1982.","journal-title":"ASCO (Abstract)"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3171\/jns.1981.54.4.0455","volume":"54","author":"FH Hochberg","year":"1981","unstructured":"Hochberg FH, Parker LM, Takvorian T et al: High dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 54:455?460, 1981.","journal-title":"J Neurosurg"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00165606","volume":"1","author":"LG Feun","year":"1983","unstructured":"Feun LG, Savaraj N, Lu K et al: The pharmacologic fate of 2,5-diaziridinyl-3,6-bis (carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles. J Neuro-Oncol 1:219?224, 1983.","journal-title":"J Neuro-Oncol"},{"key":"CR16","first-page":"992","volume":"42","author":"W-KA Yung","year":"1982","unstructured":"Yung W-KA, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42:992?998, 1982.","journal-title":"Cancer Res"},{"key":"CR17","first-page":"176","volume":"23","author":"SC Schold Jr","year":"1982","unstructured":"Schold SC Jr, Friedman HS, Bjornsson TD et al: Treatment of human brain tumors in athymic mice with aziridinylbenzoquinone (AZQ). Proc Am Assoc Can Res 23:176, 1982.","journal-title":"Proc Am Assoc Can Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000225511","volume":"38","author":"RT Eagan","year":"1981","unstructured":"Eagan RT, Creagan ET, Bisel HF et al: Phase II studies of dianhyrogalactitol-based combination chemotherapy for recurrent brain tumors. Oncology 38:4?6, 1981.","journal-title":"Oncology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00165153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00165153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00165153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T12:31:56Z","timestamp":1554726716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00165153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984]]}},"alternative-id":["BF00165153"],"URL":"https:\/\/doi.org\/10.1007\/bf00165153","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[1984]]}}}